
HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings
HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于公司董事减持计划期限届满暨实施结果的公告 | 2025-11-19 | Chinese | |
| 关于控股股东的一致行动人部分股份解除质押的公告 | 2025-10-30 | Chinese | |
| 2025年三季度报告 | 2025-10-28 | Chinese | |
| 控股子公司内部控制制度(2025年10月) | 2025-10-28 | Chinese | |
| 第九届董事会第三次会议决议公告 | 2025-10-28 | Chinese | |
| 关于控股股东的一致行动人部分股份质押的公告 | 2025-10-27 | Chinese |
Browse filings by year
23 years- 2026 48 filings
- 2025 94 filings
- 2024 76 filings
- 2023 69 filings
- 2022 61 filings
- 2021 121 filings
- 2020 134 filings
- 2019 121 filings
- 2018 204 filings
- 2017 121 filings
- 2016 128 filings
- 2015 211 filings
- 2014 200 filings
- 2013 183 filings
- 2012 112 filings
- 2011 95 filings
- 2010 80 filings
- 2009 62 filings
- 2008 66 filings
- 2007 103 filings
- 2006 60 filings
- 2005 72 filings
- 2004 39 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44367807 | 关于公司董事减持计划期限届满暨实施结果的公告 | 2025-11-19 | Chinese | ||
| 44367796 | 关于控股股东的一致行动人部分股份解除质押的公告 | 2025-10-30 | Chinese | ||
| 44367784 | 2025年三季度报告 | 2025-10-28 | Chinese | ||
| 44367757 | 控股子公司内部控制制度(2025年10月) | 2025-10-28 | Chinese | ||
| 44367743 | 第九届董事会第三次会议决议公告 | 2025-10-28 | Chinese | ||
| 44367728 | 关于控股股东的一致行动人部分股份质押的公告 | 2025-10-27 | Chinese | ||
| 44367715 | 关于参加重庆辖区2025年投资者网上集体接待日暨半年度业绩说明会活动的公告 | 2025-09-18 | Chinese | ||
| 44367707 | 关于全资子公司获得《药品注册证书》的公告 | 2025-09-16 | Chinese | ||
| 44367694 | 2025年中期权益分派实施公告 | 2025-09-08 | Chinese | ||
| 44367689 | 2025年第一次临时股东会决议公告 | 2025-09-05 | Chinese | ||
| 44367678 | 北京市时代九和律师事务所关于华邦生命健康股份有限公司2025年第一次临时股东会的法律意见书 | 2025-09-05 | Chinese | ||
| 44367658 | 关于实际控制人部分股份解除质押的公告 | 2025-09-02 | Chinese | ||
| 44367646 | 关于控股股东部分股份解除质押的公告 | 2025-08-27 | Chinese | ||
| 44367635 | 关于控股股东、实际控制人部分股份质押的公告 | 2025-08-26 | Chinese | ||
| 44367623 | 2025年中期利润分配预案 | 2025-08-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HUAPONT LIFE SCIENCES CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54070/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54070 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54070 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54070 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54070}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HUAPONT LIFE SCIENCES CO., LTD. (id: 54070)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.